CX3CR1 was also found to be expressed in more than 64% of metastatic ovarian cancer specimens, and it promotes ovarian cancer cell adhesion to the mesothelial monolayer and proliferation in a CX3CL1-dependent manner (Gurler et al., 2017; Kim et al., 2012). Here, CX3CL1 is linked to ovarian carcinoma.